NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO)

Iit Research Institute, Chicago IL

Investigators

Abstract

This task order is for safety assessment studies of Drinabant to determine its toxicity and evaluate the implications